Cargando…

Release of cyclooxygenase-2 and lipoxin A(4) from blood leukocytes in aspirin-exacerbated respiratory disease

BACKGROUND: The release of cyclooxygenase-2 (COX-2) and lipoxin A(4) (LXA(4)) from blood mononuclear cells in patients with aspirin-exacerbated respiratory disease (AERD) is only partially understood. OBJECTIVE: To investigate the presence of COX-2 and LXA(4) in peripheral blood mononuclear cells (P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rozsasi, Ajnacska, Heinemann, Akos, Keck, Tilman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OceanSide Publications, Inc. 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244273/ https://www.ncbi.nlm.nih.gov/pubmed/28107149 http://dx.doi.org/10.2500/ar.2016.7.0172

Ejemplares similares

Lipoxin and Aspirin-Triggered Lipoxins
por: Romano, Mario
Publicado: (2010)

Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing
por: Svensson, Camilla I., et al.
Publicado: (2007)

COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease
por: Crofford, Leslie J
Publicado: (2003)

Activation of Lipoxin a(4) Receptors by Aspirin-Triggered Lipoxins and Select Peptides Evokes Ligand-Specific Responses in Inflammation
por: Chiang, Nan, et al.
Publicado: (2000)

Aspirin-triggered 15-epi-lipoxin A(4) predicts cyclooxygenase-2 in the lungs of LPS-treated mice but not in the circulation: implications for a clinical test
por: Kirkby, Nicholas S., et al.
Publicado: (2013)

Lipid-Derived Mediators in Endogenous Anti-Inflammation and Resolution: Lipoxins and Aspirin-Triggered 15-epi-Lipoxins
por: Serhan, Charles N., et al.
Publicado: (2002)

Aspirin Exacerbated Respiratory Disease
por: Teran, Luis M., et al.
Publicado: (2012)

Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines
por: Hu, Shan, et al.
Publicado: (2012)

Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease
por: Garcia Cruz, Maria L., et al.
Publicado: (2012)

Novel Biphasic Role of LipoxinA(4) on Expression of Cyclooxygenase-2 in Lipopolysaccharide-Stimulated Lung Fibroblasts
por: Zheng, Shengxing, et al.
Publicado: (2011)

Blood Basophils Relevance in Chronic Rhinosinusitis with Aspirin-Exacerbated Respiratory Disease
por: Brescia, Giuseppe, et al.
Publicado: (2023)

Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease
por: Kong, Su-Kang, et al.
Publicado: (2016)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)()
por: Spies, Jonas Willian, et al.
Publicado: (2015)

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021)

Genetic Mechanisms in Aspirin-Exacerbated Respiratory Disease
por: Shrestha Palikhe, Nami, et al.
Publicado: (2012)

Aspirin-Exacerbated Respiratory Disease: Evaluation and Management
por: Lee, Rachel U., et al.
Publicado: (2011)

Update on the Management of Aspirin-Exacerbated Respiratory Disease
por: Buchheit, Kathleen M., et al.
Publicado: (2016)

Aspirin‐exacerbated respiratory disease: A review
por: Dominas, Christine, et al.
Publicado: (2020)

Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer
por: Martin-Martin, Antonia, et al.
Publicado: (2019)

Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease
por: Howe, Rachel, et al.
Publicado: (2014)

The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
por: Comhair, Suzy A. A., et al.
Publicado: (2018)

Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
por: Li, Kevin L., et al.
Publicado: (2019)

Appropriate extent of surgery for aspirin-exacerbated respiratory disease
por: Muhonen, Ethan G., et al.
Publicado: (2020)

Aspirin-exacerbated respiratory disease: Update on medical management
por: White, Andrew A., et al.
Publicado: (2020)

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
por: Sehanobish, Esha, et al.
Publicado: (2021)

Aspirin Exacerbated Respiratory Disease and Nasal Polyp Phenotyping
por: Kaboodkhani, Reza, et al.
Publicado: (2021)

Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory Disease
por: Palikhe, Nami Shrestha, et al.
Publicado: (2009)

Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances
por: Steinke, John W, et al.
Publicado: (2016)

Exonic Variants Associated with Development of Aspirin Exacerbated Respiratory Diseases
por: Shin, Seung-Woo, et al.
Publicado: (2014)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Laidlaw, Tanya M.
Publicado: (2018)

Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
por: Schneider, Sven, et al.
Publicado: (2023)

Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease
por: Mortazavi, Negar, et al.
Publicado: (2017)

The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
por: Locke, Tran, et al.
Publicado: (2020)

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6
por: Machado, Fabiana S., et al.
Publicado: (2008)

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6
por: Machado, Fabiana S., et al.
Publicado: (2009)

15-epi-lipoxin A(4)–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation
por: Paul-Clark, Mark J., et al.
Publicado: (2004)

Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial
por: Hayashi, Hiroaki, et al.
Publicado: (2020)

Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
por: Ryan, Lindsey, et al.
Publicado: (2020)

Biomarkers for predicting response to long‐term high dose aspirin therapy in aspirin‐exacerbated respiratory disease
por: Mastalerz, Lucyna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_njc58n0f811thv74fkbt9gbhsc